论文部分内容阅读
我们于1992～1995年间，由结防机构牵头，综合医院密切配合进行科研协作，对328例门诊因症求诊的初治涂阴肺结核病人，应用抗济新药迪克菲组成2HL1ZE／2L1H化疗方案，对病人采用4个月不住院全程管理，满疗程后，肺部病灶吸收率为99．7％（327／328）；停药3年，随访观察，肺部?
We from 1992 to 1995, led by the prevention and treatment agencies, the General Hospital in close collaboration with scientific research cooperation, 328 cases of outpatient treatment for first-onset smear-negative pulmonary tuberculosis patients, the application of new anti-dicki composition 2HL1ZE / 2L1H chemotherapy, The patient was not hospitalized for 4 months, the whole course of management, after the full course of treatment, the lung lesions absorption rate was 99.7% (327/328); withdrawal 3 years, follow-up observation of the lungs?